We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IDT market cap is 42.18M. The company's latest EPS is AUD -0.0154 and P/E is -7.79.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 14.1M | 16.9M | 12.13M | 7.03M | 14.02M |
| Operating Income | -2.08M | 937k | -1.88M | -9.78M | -6.06M |
| Net Income | -1.92M | 2.1M | -1.16M | -8.5M | -5.41M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 28.59M | 34.13M | 30.08M | 28.29M | 31.37M |
| Total Liabilities | 5.29M | 6.51M | 3.09M | 4.15M | 7.93M |
| Total Equity | 23.3M | 27.62M | 26.99M | 24.14M | 23.44M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.89M | 370k | -1.89M | -7.9M | -9.6M |
| Investing | -761k | -526k | -912k | -522k | -1.09M |
| Financing | 12k | 224k | 337k | 3.64M | 6.77M |
| Market Cap | 42.18M |
| Price to Earnings Ratio | -7.79 |
| Price to Sales Ratio | 3.01 |
| Price to Cash Ratio | 85.71 |
| Price to Book Ratio | 1.8 |
| Dividend Yield | - |
| Shares Outstanding | 351.48M |
| Average Volume (1 week) | 102.25k |
| Average Volume (1 Month) | 109.5k |
| 52 Week Change | 90.48% |
| 52 Week High | 0.145 |
| 52 Week Low | 0.05 |
| Spread (Intraday) | 0.01 (4.17%) |
| Company Name | Idt Australia Limited |
| Address |
45 wadhurst drive melbourne, victoria 3155 |
| Website | https://www.idtaus.com.au |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
